Literature DB >> 8134400

Interplay of positive and negative effectors in function of the C-terminal repeat domain of RNA polymerase II.

Y Li1, R D Kornberg.   

Abstract

RNA polymerase II lacking a C-terminal domain (CTD) was active in transcription with purified proteins from yeast but failed to support transcription in a yeast extract. CTD dependence could be reconstituted in the purified system by addition of two fractions from the extract. An inhibitory fraction abolished transcription by both wild-type and CTD-less RNA polymerases; a stimulatory fraction restored activity of the wild-type polymerase but had a much lesser effect on the CTD-less enzyme. Parallel results were obtained with the use of a kinase inhibitor that prevents phosphorylation of the CTD by RNA polymerase II initiation factor b. The kinase inhibitor abolished transcription by wild-type polymerase in yeast extract but had no significant effect in the purified system. The requirement for both the CTD and kinase action for transcription in an extract indicates that CTD phosphorylation is involved in opposing the negative effector in the extract. Factor b must play a role(s) in addition to phosphorylation of the CTD because it was still required for transcription with polymerase lacking a CTD in the purified system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134400      PMCID: PMC43371          DOI: 10.1073/pnas.91.6.2362

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Mutations in RNA polymerase II enhance or suppress mutations in GAL4.

Authors:  L A Allison; C J Ingles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Transcription-dependent structural changes in the C-terminal domain of mammalian RNA polymerase subunit IIa/o.

Authors:  P J Laybourn; M E Dahmus
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro.

Authors:  W A Zehring; J M Lee; J R Weeks; R S Jokerst; A L Greenleaf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  The major late promoter of adenovirus-2 is accurately transcribed by RNA polymerases IIO, IIA, and IIB.

Authors:  W Y Kim; M E Dahmus
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

6.  Messenger RNA synthesis in mammalian cells is catalyzed by the phosphorylated form of RNA polymerase II.

Authors:  D L Cadena; M E Dahmus
Journal:  J Biol Chem       Date:  1987-09-15       Impact factor: 5.157

7.  Functional redundancy and structural polymorphism in the large subunit of RNA polymerase II.

Authors:  M Nonet; D Sweetser; R A Young
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

8.  Purification and characterization of yeast RNA polymerase II general initiation factor g.

Authors:  N L Henry; M H Sayre; R D Kornberg
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

9.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

10.  Purification and properties of Saccharomyces cerevisiae RNA polymerase II general initiation factor a.

Authors:  M H Sayre; H Tschochner; R D Kornberg
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

View more
  25 in total

1.  Analysis of the open region of RNA polymerase II transcription complexes in the early phase of elongation.

Authors:  U Fiedler; H T Timmers
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Human cyclin-dependent kinase-activating kinase exists in three distinct complexes.

Authors:  R Drapkin; G Le Roy; H Cho; S Akoulitchev; D Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Chemical inhibition of the TFIIH-associated kinase Cdk7/Kin28 does not impair global mRNA synthesis.

Authors:  Elenita I Kanin; Ryan T Kipp; Charles Kung; Matthew Slattery; Agnes Viale; Steven Hahn; Kevan M Shokat; Aseem Z Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-28       Impact factor: 11.205

4.  Mapping RNA exit channel on transcribing RNA polymerase II by FRET analysis.

Authors:  Chin-Yu Chen; Chia-Chi Chang; Chi-Fu Yen; Michael T-K Chiu; Wei-Hau Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

Review 5.  Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae.

Authors:  M L Greenberg; J M Lopes
Journal:  Microbiol Rev       Date:  1996-03

6.  Three transitions in the RNA polymerase II transcription complex during initiation.

Authors:  F C Holstege; U Fiedler; H T Timmers
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

7.  The RNA polymerase II preinitiation complex formed in the presence of ATP.

Authors:  H Serizawa; Z Tsuchihashi; K Mizumoto
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

8.  A three-step pathway of transcription initiation leading to promoter clearance at an activation RNA polymerase II promoter.

Authors:  Y Jiang; M Yan; J D Gralla
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

9.  The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain.

Authors:  L C Myers; C M Gustafsson; D A Bushnell; M Lui; H Erdjument-Bromage; P Tempst; R D Kornberg
Journal:  Genes Dev       Date:  1998-01-01       Impact factor: 11.361

10.  Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast.

Authors:  J B McNeil; H Agah; D Bentley
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.